During the past decade, SUNY Upstate Medical University - Regional Oncology Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "SUNY Upstate Medical University - Regional Oncology Center" are "Small Cell Lung Cancer" (2 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Castration-Resistant Prostatic Cancer" (1 trials) and "Metastatic Prostate Cancer" (1 trials). Many other conditions were trialed in "SUNY Upstate Medical University - Regional Oncology Center" in a lesser frequency.

Most popular intervention types in "SUNY Upstate Medical University - Regional Oncology Center" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Amrubicin" (2 trials), "Topotecan" (2 trials), "Abiraterone Acetate" (1 trials), "New Formulation of Niraparib and Abiraterone Acetate (AA)" (1 trials) and "Niraparib" (1 trials). Other intervention names were less common.

The vast majority of trials in "SUNY Upstate Medical University - Regional Oncology Center" are 3 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "SUNY Upstate Medical University - Regional Oncology Center". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in SUNY Upstate Medical University - Regional Oncology Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in SUNY Upstate Medical University - Regional Oncology Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".